Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03142711 · ClinicalTrials.gov registry record
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
A clinical trial, sponsored by Lupus Research Alliance.
- Completed
- Registry status
- 80
- Enrollment target
NCT03142711: Completed study, sponsored by Lupus Research Alliance.
NCT03142711 is a clinical trial that has completed, run by Lupus Research Alliance. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03142711 has completed, sponsored by Lupus Research Alliance.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
Systemic lupus erythematosus (SLE) may involve a variety of organ systems expressed differently from patient to patient, and so can be difficult to characterize clinically. Patient reported outcomes (PROs), which consist of feedback directly from patients regarding their symptoms without interpretation by a clinician, are typically used in SLE to supplement other clinical measures. Standard PROs typically used in SLE include the 36-item short form health survey (SF-36), the functional assessment of chronic illness therapy - fatigue (FACIT-F), and the patient global assessment (PtGA), administered by paper or electronic tablet during the clinic visits. The recent development of electronic mobile device technology, such as the smartphone, has made it possible to collect PRO information away from the clinical site in the subject's environment. This study will assess by measurement equivalence testing whether data collected via a smartphone are comparable to that collected in standard fashion and whether PROs obtained in the subject's environment may be more informative than that collected in the physician's office on paper.
Primary Outcome
To evaluate measurement equivalence between the two PRO data collection modes - original paper mode versus the ePRO application on a handheld mobile phone for the following PRO's: SF-36 HRQoL questionnaire, the FACIT-F fatigue instrument, and the PtGA. The three PROs will be administered on clinic days by both modes: paper and ePRO. Concurrent results will be compared, and percentage similarities calculated.
Interventions
- OTHER No Medical Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2018-07-03 |
What the finished NCT03142711 record still lists
NCT03142711 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Medical Intervention is the first listed.
NCT03142711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03142711 about?
NCT03142711 is a clinical study titled "Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus". Systemic lupus erythematosus (SLE) may involve a variety of organ systems expressed differently from patient to patient, and so can be difficult to characterize clinically. Patient reported outcomes (PROs), which consist of feedback directly from patients regarding their symptoms without interpretat...
What is the current status of trial NCT03142711?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-08-21. Estimated completion is 2018-07-03.
What interventions are being tested in trial NCT03142711?
The interventions under investigation include: No Medical Intervention (OTHER).
Who is sponsoring clinical trial NCT03142711?
This trial is sponsored by Lupus Research Alliance, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI